Here we provide you with HIV & TB drug resistance information in the form of reports, clinical cases, tweets and publications.
In this new section of the bioafrica.net website, physicians, researchers and public health officials can learn about our drug resistance work and its application to the management of patients failing ARVs and anti-TB therapies.
By Justen Manasa - 2013-08-21
SATuRN 2013 report
By Dean Solomon and Tulio de Oliveira - 2013-08-01
SATuRN 2013 report
Major data analysis determines the trends of HIV-1 drug resistance mutations in South Africa.
By Tulio de Oliveira - 2013-07-01
SATuRN report 2013
By Tulio de Oliveira, Justen Manasa, Richard Lessells - 2013-03-16
SATuRN 2013 report
Bioafrica.net & SATuRN webpages received 186,746 visits in the past 12 months!
By Tulio de Oliveira - 2013-02-26
SATuRN 2013 report
Clinical Case Study: The Diagnosis and Management of First-line Antiretroviral Treatment Failure
By Theresa Rossouw, Tulio de Oliveira & Richard Lessells - 2013-01-16
SATuRN 2012 report
By Dominique Goedhals & Cloete van Vuuren - 2012-07-10
SATuRN 2012 report
Molecular Epidemiology and Diversity of SARS-CoV-2 in Ethiopia 2020-2022. Genes (2023), I.F.:
Genomic epidemiology of SARS-CoV-2 during the first four waves in Mozambique. PLOS Glob Public Health (2023), I.F.:
Consequences of rpoB mutations missed by the GenoType MTBDRplus assay in a programmatic setting in South Africa. Afr J Lab Med. (2023), I.F.:
New nomenclature for mpox (monkeypox) and monkeypox virus clades. Lancet Infect Dis. (2023), I.F.:
Advancing detection and response capacities for emerging and re-emerging pathogens in Africa. Lancet Infect Dis. (2023), I.F.:
SARS-CoV-2 Africa dashboard for real-time COVID-19 information. Nature Microbiology (2023), I.F.:
Rapid epidemic expansion of chikungunya virus-ECSA lineage in Paraguay. medRXiV (2023), I.F.:
Genomic epidemiology sheds light on the recent spatio-temporal dynamics of Yellow Fever virus and the spatial corridor that fueled its ongoing emergence in southern Brazil. medRxiv (2023), I.F.:
Evaluation of miniaturized Illumina DNA preparation protocols for SARS-CoV-2 whole genome sequencing. PLoS ONE (2023), I.F.:
KRISP has been created by the coordinated effort of the University of KwaZulu-Natal (UKZN), the Technology Innovation Agency (TIA) and the South African Medical Research Countil (SAMRC).
Location: K-RITH Tower Building
Nelson R Mandela School of Medicine, UKZN
719 Umbilo Road, Durban, South Africa.
Director: Prof. Tulio de Oliveira